These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15083761)

  • 1. Influence of treatment on leptin levels in patients with obstructive sleep apnoea.
    Sanner BM; Kollhosser P; Buechner N; Zidek W; Tepel M
    Eur Respir J; 2004 Apr; 23(4):601-4. PubMed ID: 15083761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Continuous Positive Airway Pressure Treatment on Leptin Levels in Patients with Obstructive Sleep Apnea Syndrome.
    Yosunkaya Ş; Okur HK; Can Ü; Zamani A; Kutlu R
    Metab Syndr Relat Disord; 2015 Aug; 13(6):272-7. PubMed ID: 25867002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between continuous positive airway pressure and circulating omentin levels in patients with obstructive sleep apnoea.
    Uygur F; Tanrıverdi H; Can M; Erboy F; Altınsoy B; Atalay F; Ornek T; Damar M; Kokturk F; Tor M
    Sleep Breath; 2016 Sep; 20(3):939-45. PubMed ID: 26810494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of obesity and obstructive sleep apnea on metabolic hormones.
    Sánchez-de-la-Torre M; Mediano O; Barceló A; Piérola J; de la Peña M; Esquinas C; Miro A; Durán-Cantolla J; Agustí AG; Capote F; Marin JM; Montserrat JM; García-Río F; Barbé F
    Sleep Breath; 2012 Sep; 16(3):649-56. PubMed ID: 21912907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral appliance therapy versus nasal continuous positive airway pressure in obstructive sleep apnoea syndrome: a randomised, placebo-controlled trial on self-reported symptoms of common sleep disorders and sleep-related problems.
    Nikolopoulou M; Byraki A; Ahlberg J; Heymans MW; Hamburger HL; De Lange J; Lobbezoo F; Aarab G
    J Oral Rehabil; 2017 Jun; 44(6):452-460. PubMed ID: 28294380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI of the pharynx and treatment efficacy of a mandibular advancement device in obstructive sleep apnoea syndrome.
    Sanner BM; Heise M; Knoben B; Machnick M; Laufer U; Kikuth R; Zidek W; Hellmich B
    Eur Respir J; 2002 Jul; 20(1):143-50. PubMed ID: 12166562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment.
    Harsch IA; Konturek PC; Koebnick C; Kuehnlein PP; Fuchs FS; Pour Schahin S; Wiest GH; Hahn EG; Lohmann T; Ficker JH
    Eur Respir J; 2003 Aug; 22(2):251-7. PubMed ID: 12952256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-α/interleukin-10 ratio in patients with obstructive sleep apnoea hypopnoea syndrome.
    Jiang H; Cao H; Wang P; Liu W; Cao F; Chen J
    J Laryngol Otol; 2015 Jan; 129(1):73-8. PubMed ID: 25496519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in ghrelin, leptin and pro-inflammatory cytokines after therapy in Obstructive Sleep Apnea Syndrome (OSAS) patients.
    De Santis S; Cambi J; Tatti P; Bellussi L; Passali D
    Otolaryngol Pol; 2015; 69(2):1-8. PubMed ID: 26224223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mandibular advancement surgery in patients with severe obstructive sleep apnea uncontrolled by continuous positive airway pressure. A retrospective review of 25 patients between 1998 and 2004].
    Dekeister C; Lacassagne L; Tiberge M; Montemayor T; Migueres M; Paoli JR
    Rev Mal Respir; 2006 Nov; 23(5 Pt 1):430-7. PubMed ID: 17314742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A custom-made mandibular repositioning device for obstructive sleep apnoea-hypopnoea syndrome: the ORCADES study.
    Vecchierini MF; Attali V; Collet JM; d'Ortho MP; El Chater P; Kerbrat JB; Leger D; Monaca C; Monteyrol PJ; Morin L; Mullens E; Pigearias B; Meurice JC;
    Sleep Med; 2016 Mar; 19():131-40. PubMed ID: 26364869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of continuous positive airway pressure and mandibular advancement devices on sleepiness in patients with obstructive sleep apnoea: a network meta-analysis.
    Bratton DJ; Gaisl T; Schlatzer C; Kohler M
    Lancet Respir Med; 2015 Nov; 3(11):869-78. PubMed ID: 26497082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome.
    Sanner BM; Klewer J; Trumm A; Randerath W; Kreuzer I; Zidek W
    Eur Respir J; 2000 Jul; 16(1):118-22. PubMed ID: 10933096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-specific change in leptin concentrations during long-term CPAP therapy.
    Aro M; Anttalainen U; Kurki S; Irjala K; Polo O; Saaresranta T
    Sleep Breath; 2020 Mar; 24(1):191-199. PubMed ID: 31055727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Obstructive Sleep Apnoea and Nasal Continuous Positive Airway Pressure on Circulating Ischaemia-Modified Albumin Concentrations.
    Uygur F; Tanriverdi H; Can M; Ornek T; Erboy F; Altinsoy B; Atalay F; Damar M; Kokturk F; Tor M
    Mediators Inflamm; 2016; 2016():8907314. PubMed ID: 26903714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced sleep endoscopy as a selection tool for mandibular advancement therapy by oral device in patients with mild to moderate obstructive sleep apnoea.
    De Corso E; Bastanza G; Della Marca G; Grippaudo C; Rizzotto G; Marchese MR; Fiorita A; Sergi B; Meucci D; Di Nardo W; Paludetti G; Scarano E
    Acta Otorhinolaryngol Ital; 2015 Dec; 35(6):426-32. PubMed ID: 26900249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of titrable thermoplastic versus custom-made mandibular advancement device for the treatment of obstructive sleep apnoea.
    Gagnadoux F; Nguyen XL; Le Vaillant M; Priou P; Meslier N; Eberlein A; Kun-Darbois JD; Chaufton C; Villiers B; Levy M; Trzépizur W; Launois S
    Respir Med; 2017 Oct; 131():35-42. PubMed ID: 28947040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Never say never: circumventing a contraindication to control apnoea-induced epileptic events with a mandibular advancement device.
    Fenton JE; Fitzgerald C; Dillon PJ; O'Shea D
    J Laryngol Otol; 2018 Nov; 132(11):1036-1038. PubMed ID: 30394239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: an observational study.
    Anandam A; Patil M; Akinnusi M; Jaoude P; El-Solh AA
    Respirology; 2013 Nov; 18(8):1184-90. PubMed ID: 23731062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
    Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.